Biomarkers in stress related diseases/disorders: diagnostic, prognostic, and therapeutic values

K Dhama, SK Latheef, M Dadar, HA Samad… - Frontiers in molecular …, 2019 - frontiersin.org
Various internal and external factors negatively affect the homeostatic equilibrium of
organisms at the molecular to the whole-body level, inducing the so-called state of stress …

Biological biomarkers of oral cancer

A Radaic, P Kamarajan, A Cho, S Wang… - Periodontology …, 2024 - Wiley Online Library
The oral squamous cell carcinoma (OSCC) 5 year survival rate of 41% has marginally
improved in the last few years, with less than a 1% improvement per year from 2005 to 2017 …

Salivary cytokines as biomarkers for oral squamous cell carcinoma: a systematic review

E Ferrari, ME Pezzi, D Cassi, TA Pertinhez… - International journal of …, 2021 - mdpi.com
The prognosis of patients with oral squamous carcinoma (OSCC) largely depends on the
stage at diagnosis, the 5-year survival rate being approximately 30% for advanced tumors …

Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis

MMA Chiamulera, CB Zancan, AP Remor, MF Cordeiro… - BMC cancer, 2021 - Springer
Background Oral cancer (OC) is usually diagnosed at advanced clinical stages due to its
asymptomatic nature and absence of pathognomonic signs in its early development phase …

Inflammatory mediators in oral cancer: pathogenic mechanisms and diagnostic potential

SE Niklander - Frontiers in Oral Health, 2021 - frontiersin.org
Approximately 15% of cancers are attributable to the inflammatory process, and growing
evidence supports an association between oral squamous cell carcinoma (OSCC) and …

Role of salivary MicroRNA and cytokines in the diagnosis and prognosis of oral squamous cell carcinoma

FJ Manzano-Moreno, VJ Costela-Ruiz… - International journal of …, 2021 - mdpi.com
Oral squamous cell carcinoma (OSCC) is the most prevalent oral malignant tumor
worldwide. An early diagnosis can have a major positive impact on its prognosis. Human …

Molecular pathways of oral submucous fibrosis and its progression to malignancy

K Gayathri, N Malathi, V Gayathri, PN Adtani… - Archives of oral …, 2023 - Elsevier
Objective The review aims to comprehend various factors engaged in the alteration of
molecular events resulting in Oral submucous fibrosis (OSMF) and its malignant …

Randomized, double-blind, placebo-controlled trial of MUC1 peptide vaccine for prevention of recurrent colorectal adenoma

RE Schoen, LA Boardman, M Cruz-Correa… - Clinical Cancer …, 2023 - AACR
Purpose: To assess whether MUC1 peptide vaccine produces an immune response and
prevents subsequent colon adenoma formation. Patients and Methods: Multicenter, double …

Clinical multi-omics strategies for the effective cancer management

BC Yoo, KH Kim, SM Woo, JK Myung - Journal of proteomics, 2018 - Elsevier
Cancer is a global health issue as a multi-factorial complex disease, and early detection and
novel therapeutic strategies are required for more effective cancer management. With the …

Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors–A systematic review

NS Piyarathne, R Rasnayake… - Expert Review of …, 2021 - Taylor & Francis
Introduction Oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders
(OPMD) are a significant health burden globally. Smoking, alcohol, and betel quid are the …